1 Patient, 7 Tumors and 100B Cells Equal 1 Striking Recovery
nytimes.com
nytimes.com
* Steve Rosenberg's a respected expert in the field
* Adoptive T cell therapy (ACT) of TIL (tumor-infiltrating lymphocytes) T cells specific for a (common) KRAS mutation (G12D)
* Culture/expand TILs, use tandem-minigenes to narrow down most reactive (to in silico ID mutations) TILs, then use synthetic peptides on the mutations encoded in the TMG that elicits largest response to find which epitopes in particular were being reacted to.
* 6 tumors eradicated, 7th shrunk but recurred (had to be resected, patient has no disease 4 months later); 7th had lost the HLA-C allele that the TCRs were specific to
* The supplementary materials/methods were pretty interesting (very technical)
[1] T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer http://www.nejm.org/doi/full/10.1056/NEJMoa1609279
The problem is that many phages are quite narrow in specificity and will only attack single specific strains of individual bacterial species. To do what you want to do you need a very large number of different phages.
There is a solution to this problem which is to isolate broad host range phages. My lab was quite successful in finding these phages. I do miss working in this area :(